Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kedar

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in miceE Kedar, E Braun, Y Rutkowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in miceE Kedar, O Palgi, G Golod, et al.
Transplantation|May 1, 1991
A short human and mouse MLR assay utilizing lymphokine (IL-2, IL-3) secretion as an early activation eventA Bishara, E Kedar, B Leshem, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomesE Kedar, Y Rutkowski, E Braun, et al.
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Journal of Immunological Methods|June 28, 1988
Typing of HLA class II and class I antigens using PHA-activated, IL-2-propagated T lymphocytesB Leshem, I Cohen, L Sherman, et al.
International Journal of Cancer|May 15, 1986
Characterization of a tumorigenic murine T-lymphoid-cell line spontaneously derived from an IL-2-dependent T-cell lineV Mann, M Szyf, A Razin, et al.
Vaccine|April 9, 1999
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in miceI Babai, S Samira, Y Barenholz, et al.
Vaccine|April 9, 1999
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in miceI Babai, S Samira, Y Barenholz, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1982
A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responsesE Kedar, B L Ikejiri, G D Bonnard, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilized liposomes: immunomodulatory and anti-tumor activity in miceE Kedar, E Braun, Y Rutkowski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 1, 1997
Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in miceE Kedar, O Palgi, G Golod, et al.
Transplantation|May 1, 1991
A short human and mouse MLR assay utilizing lymphokine (IL-2, IL-3) secretion as an early activation eventA Bishara, E Kedar, B Leshem, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomesE Kedar, Y Rutkowski, E Braun, et al.
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Journal of Immunological Methods|June 28, 1988
Typing of HLA class II and class I antigens using PHA-activated, IL-2-propagated T lymphocytesB Leshem, I Cohen, L Sherman, et al.
International Journal of Cancer|May 15, 1986
Characterization of a tumorigenic murine T-lymphoid-cell line spontaneously derived from an IL-2-dependent T-cell lineV Mann, M Szyf, A Razin, et al.
Vaccine|April 9, 1999
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in miceI Babai, S Samira, Y Barenholz, et al.
Vaccine|April 9, 1999
A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in miceI Babai, S Samira, Y Barenholz, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1982
A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responsesE Kedar, B L Ikejiri, G D Bonnard, et al.
Pageof 7